Scholar Rock Holding (SRRK) Return on Capital Employed Growth (3y) (2021 - 2026)
Scholar Rock Holding (SRRK) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | -3,782.00 |
| 10 | Scholar Rock Holding | 6.25 Bn | 6.25 Bn | - | -4,573.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,573.00 |
| Dec 31, 2025 | -6,932.00 |
| Sep 30, 2025 | -8,073.00 |
| Jun 30, 2025 | -5,981.00 |
| Mar 31, 2025 | -2,353.00 |
| Dec 31, 2024 | -3,520.00 |
| Sep 30, 2024 | -9,286.00 |
| Jun 30, 2024 | -5,953.00 |
| Mar 31, 2024 | -4,353.00 |
| Dec 31, 2023 | -3,180.00 |
| Sep 30, 2023 | -1,034.00 |
| Jun 30, 2023 | -957.00 |
| Mar 31, 2023 | -1,605.00 |
| Dec 31, 2022 | -561.00 |
| Sep 30, 2022 | 143.00 |
| Jun 30, 2022 | -603.00 |
| Mar 31, 2022 | -597.00 |
| Dec 31, 2021 | -1,034.00 |
| Sep 30, 2021 | -787.00 |